SCHEDULE: FMR LLC Discloses Stake in Bruker Corp

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 12.4% in Bruker Corp's common stock as of March 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed a Schedule 13G, indicating their beneficial ownership of Bruker Corp's common stock.
• As of March 31, 2026, the total beneficial ownership reported is 19,208,582.41 shares, representing 12.4% of the class.
• FMR LLC, an investment adviser, holds the majority of the shares, with Abigail P. Johnson also listed as a reporting person.
• The filing indicates that while FMR LLC has sole voting power over 14,435,518.96 shares, the aggregate beneficial ownership for dispositive power is 19,208,582.41 shares.
• No single other person is known to have a beneficial interest exceeding five percent of the outstanding common stock.
• The filing is an amendment (Amendment No. 10) to a previous filing.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership and does not provide performance data or strategic updates for Bruker Corp.

Positives

• Significant beneficial ownership stake of 12.4% in Bruker Corp by FMR LLC and Abigail P. Johnson.
• The reporting persons are classified as investment advisers, suggesting a professional investment approach.
• The filing confirms that no single external party holds more than 5% of the shares, potentially indicating a dispersed ownership structure among other large holders.

Negatives

• The filing does not contain specific financial performance data for Bruker Corp, focusing solely on ownership.
• The exact nature of the relationship between FMR LLC and Abigail P. Johnson regarding voting and dispositive power is detailed but complex, with shared powers being zero for voting and dispositive power between them.

Risks

• Potential for significant influence on Bruker Corp's control or strategic decisions due to the substantial ownership stake.
• The filing does not detail any specific risks related to Bruker Corp's business operations or financial health.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding Bruker Corp's future performance. It solely reports on beneficial ownership.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
• The filing notes that one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of BRUKER CORP, but no one other person's interest exceeds five percent.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors like FMR LLC, indicating significant holdings in publicly traded companies. This filing confirms FMR LLC's substantial investment in the scientific instruments and life sciences sector, where Bruker Corp operates.

Stakeholder Impact

• Shareholders: The significant stake held by FMR LLC may influence market perception and potential future corporate actions.
• Management of Bruker Corp: May need to consider the influence of a large institutional investor in strategic decision-making.
• Other Investors: Provides transparency on a major shareholder, aiding in investment analysis.

Next Steps

• Continued monitoring of FMR LLC's ownership stake in Bruker Corp for any future changes or disclosures.
• Analysis of Bruker Corp's subsequent financial reports and strategic announcements to understand the implications of this ownership.

Key Dates

Keywords

Bruker Corp, Schedule 13G, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Securities Exchange Act